| RMFEX | VCIGX | RMFEX / VCIGX | |
| Total Expense Ratio | 0.62 | 0.67 | 93% |
| Annual Report Gross Expense Ratio | 0.62 | 0.82 | 76% |
| Fund Existence | 23 years | 25 years | - |
| Gain YTD | 13.076 | 8.672 | 151% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 250 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 110B | 507M | 21,696% |
| Annual Yield % from dividends | 1.46 | 2.03 | 72% |
| Returns for 1 year | 6.34 | 5.30 | 119% |
| Returns for 3 years | 29.13 | 11.89 | 245% |
| Returns for 5 years | 55.02 | 33.04 | 167% |
| Returns for 10 years | 92.11 | 25.62 | 360% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| PSMJ | 31.48 | 0.03 | +0.10% |
| Pacer Swan SOS Moderate (July) ETF | |||
| RYLG | 22.11 | -0.01 | -0.06% |
| Global X Russell 2000 Cov Cl & Gr ETF | |||
| XSOE | 38.08 | -0.11 | -0.29% |
| WisdomTree EmMkts ex-Stt-Ownd EntrprsETF | |||
| DJD | 56.11 | -0.17 | -0.30% |
| Invesco Dow Jones Industrial Avg Div ETF | |||
| THNR | 25.13 | -0.08 | -0.33% |
| Amplify Weight Loss Drug & Treatment ETF | |||